Cuba vs Micronesia, Federated States of: Tuberculosis treatment success rate
Cuba
88.0%
in 2023
Micronesia, Federated States of
88.0%
in 2023
Cuba rank
69th
Micronesia, Federated States of rank
69th
Tuberculosis treatment success rate over time
- Cuba
- Micronesia, Federated States of
How they compare
Cuba currently reports 88.0% against 88.0% in Micronesia, Federated States of, a difference of 0.0%.
The two have swapped places 9 times across 26 shared years of data; in 1994 it was Cuba ahead.
Cuba ranks 69th and Micronesia, Federated States of ranks 69th of 206 countries.
Across the 4 decades both report, Cuba averaged higher in 2 and Micronesia, Federated States of in 2.
Head to head by decade
| Decade | Cuba | Micronesia, Federated States of | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 89.8% | 79.5% | 10.2% | Cuba |
| 2000s | 91.2% | 82.5% | 8.7% | Cuba |
| 2010s | 84.1% | 88.7% | 4.6% | Micronesia, Federated States of |
| 2020s | 82.7% | 86.0% | 3.3% | Micronesia, Federated States of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Cuba or Micronesia, Federated States of?
- Cuba, at 88.0% against 88.0% in Micronesia, Federated States of as of 2023.
- What is the difference in tuberculosis treatment success rate between Cuba and Micronesia, Federated States of?
- 0.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Micronesia, Federated States of?
- 26 years are reported by both, from 1994 to 2023.
- How do Cuba and Micronesia, Federated States of rank globally for tuberculosis treatment success rate?
- Cuba ranks 69th and Micronesia, Federated States of ranks 69th of 206 countries.
- Where does this data come from?
- WHO (2025) β with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.